title: Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
authors.forename: Maria
authors.initials: M
authors.lastname: Buti
authors.forename: Montserrat
authors.initials: M
authors.lastname: Cotrina
authors.forename: Auristela
authors.initials: A
authors.lastname: Valdes
authors.forename: Rosendo
authors.initials: R
authors.lastname: Jardi
authors.forename: Francisco
authors.initials: F
authors.lastname: Rodriguez-Frias
authors.forename: Rafael
authors.initials: R
authors.lastname: Esteban
mesh_terms: D004352:Drug Resistance, Microbial; D006509:Hepatitis B / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine